Fusion Pharmaceuticals Inc. Annual Income Tax Expense (Benefit) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Fusion Pharmaceuticals Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2019 to 2023.
  • Fusion Pharmaceuticals Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$237K, a 2055% decline year-over-year.
  • Fusion Pharmaceuticals Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was $561K.
  • Fusion Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2023 was $787K.
  • Fusion Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2022 was -$1.84M, a 1457% decline from 2021.
  • Fusion Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2021 was -$118K, a 105% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $787K +$2.62M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 -$1.84M -$1.72M -1457% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 -$118K -$2.73M -105% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $2.61M +$2.36M +940% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 $251K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.